Login / Signup

Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis Registry.

Carly GrantLourdes M Perez-ChadaRyan W HarrisonRobert R McLeanBlessing DubeMargaux M CrabtreeAlice B GottliebJoseph F Merola
Published in: Clinical and experimental dermatology (2024)
The similar profiles between screen-positive and PsA groups, in comparison with the screen-negative group, support observations of possible underdiagnosis of PsA and the increased impact of disease, especially musculoskeletal disease, among patients who screen positive for PsA. The high percentage of patients not at an acceptable symptom state in the PsA and screen-positive groups highlights the need to optimize care in PsA.
Keyphrases
  • prostate cancer
  • high throughput
  • radical prostatectomy
  • end stage renal disease
  • ejection fraction
  • palliative care
  • newly diagnosed
  • peritoneal dialysis
  • chronic pain
  • patient reported
  • pain management
  • single cell